MPWT
LYEL icon

MassMutual Private Wealth & Trust’s Lyell Immunopharma LYEL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7
Closed -$1K – 1628
2022
Q1 		$1K Buy
+7
New +$848 ﹤0.01% 1363

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MassMutual Private Wealth & Trust's LYEL Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Lyell Immunopharma (LYEL) in Q2 2022, closing a stake of 7 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in LYEL in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 75 funds tracked by Wall St. Rank hold LYEL as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Lyell Immunopharma position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 7 Lyell Immunopharma shares in Q2 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Lyell Immunopharma in Q1 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Lyell Immunopharma position peaked at $1K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.